| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.04B | -1.5% |
| Cost of Revenue | $1.68B | -0.5% |
| Gross Profit | $2.36B | -2.2% |
| R&D Expense | $29.6M | +15.6% |
| SG&A Expense | $1.47B | +5.8% |
| Operating Income | $149.5M | -85.4% |
| Pre-tax Income | $73.0M | -92.0% |
| Income Tax | $154.2M | +490.5% |
| Net Income | -$81.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $130.4M | -27.8% |
| Accounts Receivable | $278.2M | +8.0% |
| Inventory | $368.7M | +3.5% |
| Current Assets | $885.9M | +1.6% |
| Total Assets | $4.17B | -13.2% |
| Current Liabilities | $700.1M | -5.4% |
| Long-term Debt | $1.23B | -8.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $710.4M | -28.4% |
| Capital Expenditures | $51.2M | -26.1% |
| Investing Cash Flow | -$51.2M | +26.1% |
| Financing Cash Flow | -$714.6M | +19.4% |
| Free Cash Flow | $659.2M | -28.6% |
| -108.5% |
| EPS (Basic) | -$1.50 | -109.4% |
| EPS (Diluted) | -$1.50 | -109.4% |
| Total Liabilities |
| $2.88B |
| -3.2% |
| Stockholders' Equity | $1.29B | -29.5% |